Markets:

Overview

News

Currencies

International

Treasuries

MaxCyte, Inc. - Common Stock (NQ:MXCT)

0.7400 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MaxCyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Crude Oil Down 2%; ConAgra Brands Earnings Top Views ↗

October 05, 2023

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. The Dow traded down 0.12% to 33,088.44 while the NASDAQ fell 0.23% to...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 05, 2023

Via Benzinga

Why Shares of MaxCyte Are Plummeting on Thursday ↗

October 05, 2023

The biotech company reduced full-year guidance and expects so-so third-quarter revenue.

Via The Motley Fool

Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast ↗

October 05, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.45% to 32,980.31 while the NASDAQ fell 0.62% to 13,154.24. The...

Via Benzinga

Topics Stocks

BB Stock Alert: What to Know as BlackBerry Plans IPO for IoT Division ↗

October 05, 2023

BlackBerry stock is a hot topic among BB shareholders today alongside news the company is considering an IPO for its IoT business.

Via InvestorPlace

Topics Initial Public Offering

Recap: MaxCyte Q1 Earnings ↗

May 10, 2023

Via Benzinga

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 05, 2023

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 05, 2023

Via Benzinga

Why Is MaxCyte (MXCT) Stock Down 21% Today? ↗

October 05, 2023

MaxCyte stock is taking a beating on Thursday as investors in MXCT shares react to preliminary results for its third quarter of 2023.

Via InvestorPlace

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket ↗

October 05, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 05, 2023

Pre-market stock movers are rising and falling on Thursday as we check out all of the latest news worth knowing about this morning!

Via InvestorPlace

MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 05, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday ↗

October 05, 2023

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 04, 2023

Via Benzinga

MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance

October 04, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing

September 06, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte to Participate in Baird Global Healthcare Conference

September 05, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Reports Second Quarter and Half-Year 2023 Financial Results and Updates Full Year 2023 Guidance

August 09, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients

August 01, 2023

Prime Medicine to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to advance their innovative Prime Editing technology and develop a new class of one-time, potentially curative...

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023

July 13, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte and Vittoria Biotherapeutics Sign Strategic Platform License to Advance Next Generation Cellular Therapies

July 10, 2023

MaxCyte’s Flow Electroporation® technology and ExPERT™ platform will support Vittoria’s Senza5™ technology to enhance efficacy and improve clinical utility of T-cell therapies.

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Signs Strategic Platform License with Lyell Immunopharma

July 06, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte to Participate in Upcoming Investor Conferences

June 01, 2023

From MaxCyte, Inc

Via GlobeNewswire

Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 11, 2023

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.

Via Benzinga

Disney, Sonos, Desktop Metal And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

May 11, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Sonos, Inc. (NASDAQ: SONO) shares dipped 25.2% to $15.82 in pre-market...

Via Benzinga

MaxCyte Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Guidance

May 10, 2023

From MaxCyte, Inc

Via GlobeNewswire

MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform

May 04, 2023

Walking Fish to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to engineer novel B-cell based medicines for the treatment of serious diseases

From MaxCyte, Inc

Via GlobeNewswire

7 Small-Cap Biotech Stocks with Massive Potential ↗

April 27, 2023

Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

Via InvestorPlace

MaxCyte to Report First Quarter 2023 Financial Results on May 10, 2023

April 12, 2023

From MaxCyte, Inc

Via GlobeNewswire

Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

March 31, 2023

The Dow Jones closed higher by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or ...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.